Martine Rothblatt's Common Stock Sales in United Therapeutics Corp

Martine Rothblatt, the Founder, Chairperson, and CEO of United Therapeutics Corp, has filed a notice of sale of common stock. The filing details the sale of 4,000 shares on October 24, 2025, with an aggregate market value of $1,696,259.60. Additionally, the filing discloses multiple sales of common stock over the past three months, totaling 112,000 shares with gross proceeds exceeding $18 million. The securities were sold through TD Securities (USA) LLC. The filing also mentions that Rothblatt acquired 294,000 shares on March 15, 2016, as part of an Executive Deferred Compensation plan.